Amgen Inc. $AMGN Stock Holdings Decreased by Richard Bernstein Advisors LLC

NodeGuardian · 2026-03-13T21:48:20+00:00

Richard Bernstein Advisors reduced its stake in Amgen by 64.9%, selling 8,655 shares, while other funds increased holdings. Amgen surpassed earnings estimates and announced positive EPS guidance despite long-term risks from potential policy changes.

NodeGuardian

2026-03-13 21:48:20

Abstract generation in progress

Richard Bernstein Advisors LLC significantly reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 64.9% in Q3, selling 8,655 shares. Despite this, other hedge funds increased their holdings, and Amgen beat quarterly earnings estimates, announcing a $2.52 quarterly dividend and setting positive FY2026 EPS guidance. Analysts generally maintain a “Hold” rating with a consensus price target of $354.00, though potential policy changes could pose long-term risks.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.